160 related articles for article (PubMed ID: 15386377)
1. Association of lipoprotein lipase gene polymorphism with risk of prostate cancer in a Japanese population.
Narita S; Tsuchiya N; Wang L; Matsuura S; Ohyama C; Satoh S; Sato K; Ogawa O; Habuchi T; Kato T
Int J Cancer; 2004 Dec; 112(5):872-6. PubMed ID: 15386377
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of the lipoprotein lipase gene and risk of atherothrombotic cerebral infarction in the Japanese.
Shimo-Nakanishi Y; Urabe T; Hattori N; Watanabe Y; Nagao T; Yokochi M; Hamamoto M; Mizuno Y
Stroke; 2001 Jul; 32(7):1481-6. PubMed ID: 11441189
[TBL] [Abstract][Full Text] [Related]
3. Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population.
Li Z; Habuchi T; Mitsumori K; Kamoto T; Kinoshitu H; Segawa T; Ogawa O; Kato T
J Urol; 2003 Jun; 169(6):2378-81. PubMed ID: 12771801
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer.
Wang L; Habuchi T; Tsuchiya N; Mitsumori K; Ohyama C; Sato K; Kinoshita H; Kamoto T; Nakamura A; Ogawa O; Kato T
Cancer Res; 2003 Aug; 63(15):4407-11. PubMed ID: 12907612
[TBL] [Abstract][Full Text] [Related]
5. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.
Habuchi T; Suzuki T; Sasaki R; Wang L; Sato K; Satoh S; Akao T; Tsuchiya N; Shimoda N; Wada Y; Koizumi A; Chihara J; Ogawa O; Kato T
Cancer Res; 2000 Jan; 60(2):305-8. PubMed ID: 10667581
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population.
Ma Z; Tsuchiya N; Yuasa T; Inoue T; Kumazawa T; Narita S; Horikawa Y; Tsuruta H; Obara T; Saito M; Satoh S; Ogawa O; Habuchi T
Int J Cancer; 2008 Dec; 123(11):2574-9. PubMed ID: 18756523
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.
Habuchi T; Liqing Z; Suzuki T; Sasaki R; Tsuchiya N; Tachiki H; Shimoda N; Satoh S; Sato K; Kakehi Y; Kamoto T; Ogawa O; Kato T
Cancer Res; 2000 Oct; 60(20):5710-3. PubMed ID: 11059764
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk.
Singal R; Ferdinand L; Das PM; Reis IM; Schlesselman JJ
Int J Oncol; 2004 Nov; 25(5):1465-71. PubMed ID: 15492840
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
[TBL] [Abstract][Full Text] [Related]
10. DNA polymorphisms of the lipoprotein lipase gene and their association with coronary artery disease in the Saudi population.
Al-Jafari AA; Daoud MS; Mobeirek AF; Al Anazi MS
Int J Mol Sci; 2012; 13(6):7559-7574. PubMed ID: 22837712
[TBL] [Abstract][Full Text] [Related]
11. Effects of the T-786C, G894T, and Intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1132-40. PubMed ID: 22317880
[TBL] [Abstract][Full Text] [Related]
12. Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population.
Suzuki K; Ohtake N; Nakata S; Takei T; Matsui H; Ono Y; Nakazato H; Hasumi M; Koike H; Ito K; Fukabori Y; Kurokawa K; Yamanaka H
Anticancer Res; 2002; 22(6B):3507-11. PubMed ID: 12552947
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.
Gunes S; Bagci H; Sarikaya S; Bilen CY; Kara N
DNA Cell Biol; 2007 Dec; 26(12):873-8. PubMed ID: 17961073
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the lipoprotein lipase gene are associated with atherosclerotic cerebral infarction in the Chinese.
Xu E; Li W; Zhan L; Guan G; Wang X; Chen S; Shi Y
Neuroscience; 2008 Aug; 155(2):403-8. PubMed ID: 18590804
[TBL] [Abstract][Full Text] [Related]
15. Association of PvuII polymorphism in the lipoprotein lipase gene with the coronary artery disease in Macedonian population.
Georgiev A; Panov S; Sadikario S
Prilozi; 2008 Dec; 29(2):213-25. PubMed ID: 19259048
[TBL] [Abstract][Full Text] [Related]
16. Significance of vitamin D receptor gene polymorphism for risk and disease severity of prostate cancer and benign prostatic hyperplasia in Japanese.
Hamasaki T; Inatomi H; Katoh T; Ikuyama T; Matsumoto T
Urol Int; 2002; 68(4):226-31. PubMed ID: 12053022
[TBL] [Abstract][Full Text] [Related]
17. Significance of an E-cadherin gene promoter polymorphism for risk and disease severity of prostate cancer in a Japanese population.
Goto T; Nakano M; Ito S; Ehara H; Yamamoto N; Deguchi T
Urology; 2007 Jul; 70(1):127-30. PubMed ID: 17656222
[TBL] [Abstract][Full Text] [Related]
18. Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study.
Safarinejad MR; Shafiei N; Safarinejad S
Prostate; 2010 Nov; 70(15):1645-57. PubMed ID: 20564317
[TBL] [Abstract][Full Text] [Related]
19. Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer.
Tanaka Y; Sasaki M; Shiina H; Tokizane T; Deguchi M; Hirata H; Hinoda Y; Okayama N; Suehiro Y; Urakami S; Kawakami T; Kaneuchi M; Pookot D; Igawa M; Okuyama A; Ishii N; Dahiya R
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):238-44. PubMed ID: 16492910
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein Lipase (LPL) Polymorphism and the Risk of Coronary Artery Disease: A Meta-Analysis.
Xie L; Li YM
Int J Environ Res Public Health; 2017 Jan; 14(1):. PubMed ID: 28275220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
